POSC283 Number Needed to Treat and Incremental Costs per Responder for Biologics and Targeted Synthetic Drugs in Adult Patients with Active Psoriatic Arthritis in the Russian Federation
Abstract
Authors
V Mladov V Sokolova D Tolkacheva